45 results
6-K
EX-10.1
QNTM
Quantum BioPharma Ltd
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
424B5
QNTM
Quantum BioPharma Ltd
16 Feb 24
Prospectus supplement for primary offering
6:36pm
;
the Corporation’s ability to successfully develop new commercialized products or find a market for their sale;
the impact of any future recall … recall or removal would result in additional costs to the Corporation, including lost revenues from any products that we are required to remove from
F-3
QNTM
Quantum BioPharma Ltd
22 Dec 23
Shelf registration (foreign)
6:49pm
;
the impact of any future recall of the Corporation’s products;
the Corporation’s ability to promote and sustain its products, including any restrictions … a particular product from the market. Any recall or removal would result in additional costs to the Corporation, including lost revenues from any products
6-K
EX-99.3
QNTM
Quantum BioPharma Ltd
25 Aug 23
FSD Pharma Signs Definitive Agreement to Launch UNBUZZD, a
4:18pm
including the duration of the arrangement, the number or principal amount of securities involved and any right to recall the securities or identical
6-K
EX-99.2
ncvgu7v4zh
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.2
jjz7wcfk462zzn bekfp
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.2
vl2auhk
13 May 22
Condensed consolidated interim financial statements
5:10pm
20-F
EX-15.1
3wpenbi
31 Mar 22
Annual report (foreign)
8:09am
20-F
gq1ub7o7
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
dzg0p3awj7qhyw
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm
6-K
EX-99.1
571jraph
21 Sep 21
THIS AGREEMENT made as of the 25th day of August, 2021
4:02pm
6-K
EX-99.1
kb6n32xe m4
12 Aug 21
Management's Discussion and Analysis of Financial Condition and Results of
9:53pm
6-K
EX-99.2
vkfuhqm
7 May 21
Condensed consolidated interim financial statements
4:38pm
F-10
nayuo6udrzx2eatf2
2 Apr 21
Registration of securities (Canada)
12:49pm
40-F
EX-99.3
mp4x1h3a
17 Mar 21
Annual report (Canada)
12:00am
40-F
l75 2ivjz579w
17 Mar 21
Annual report (Canada)
12:00am
40-F
EX-99.1
xcabw466kb bl
17 Mar 21
Annual report (Canada)
12:00am